Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia.


Journal

JAMA otolaryngology-- head & neck surgery
ISSN: 2168-619X
Titre abrégé: JAMA Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 101589542

Informations de publication

Date de publication:
01 07 2023
Historique:
pmc-release: 11 05 2024
medline: 17 7 2023
pubmed: 11 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

Otologic disease is common among people with primary ciliary dyskinesia (PCD), yet little is known about its spectrum and severity. To characterize otologic disease among participants with PCD using data from the Ear-Nose-Throat Prospective International Cohort. This cross-sectional analysis of baseline cohort data from February 2020 through July 2022 included participants from 12 specialized centers in 10 countries. Children and adults with PCD diagnoses; routine ear, nose, and throat examinations; and completed symptom questionnaires at the same visit or within 2 weeks were prospectively included. Potential risk factors associated with increased risk of ear disease. The prevalence and characteristics of patient-reported otologic symptoms and findings from otologic examinations, including potential factors associated with increased risk of ear inflammation and hearing impairment. A total of 397 individuals were eligible to participate in this study (median [range] age, 15.2 [0.2-72.4] years; 186 (47%) female). Of the included participants, 204 (51%) reported ear pain, 110 (28%) reported ear discharge, and 183 (46%) reported hearing problems. Adults reported ear pain and hearing problems more frequently when compared with children. Otitis media with effusion-usually bilateral-was the most common otoscopic finding among 121 of 384 (32%) participants. Retracted tympanic membrane and tympanic sclerosis were more commonly seen among adults. Tympanometry was performed for 216 participants and showed pathologic type B results for 114 (53%). Audiometry was performed for 273 participants and showed hearing impairment in at least 1 ear, most commonly mild. Season of visit was the strongest risk factor for problems associated with ear inflammation (autumn vs spring: odds ratio, 2.40; 95% CI, 1.51-3.81) and age 30 years and older for hearing impairment (41-50 years vs ≤10 years: odds ratio, 3.33; 95% CI, 1.12-9.91). In this cross-sectional study, many people with PCD experienced ear problems, yet frequency varied, highlighting disease expression differences and possible clinical phenotypes. Understanding differences in otologic disease expression and progression during lifetime may inform clinical decisions about follow-up and medical care. Multidisciplinary PCD management should be recommended, including regular otologic assessments for all ages, even without specific complaints.

Identifiants

pubmed: 37166807
pii: 2804958
doi: 10.1001/jamaoto.2023.0841
pmc: PMC10176184
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

587-596

Auteurs

Myrofora Goutaki (M)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Paediatric Respiratory Medicine, Children's University Hospital of Bern, University of Bern, Bern, Switzerland.

Yin Ting Lam (YT)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Mihaela Alexandru (M)

Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Hôpital Bicêtre, Service d'ORL, Le Kremlin-Bicêtre, France.
Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Andreas Anagiotos (A)

Department of Otorhinolaryngology, Nicosia General Hospital, Nicosia, Cyprus.

Miguel Armengot (M)

Department of Otorhinolaryngology and Primary Ciliary Dyskinesia Unit, La Fe University and Polytechnic Hospital, Valencia, Spain.
University of Valencia Medical School, Valencia, Spain.

Mieke Boon (M)

Department of Paediatrics, University Hospital, Leuven, Belgium.

Andrea Burgess (A)

Primary Ciliary Dyskinesia Centre, Southampton Children's Hospital, Southampton NHS Foundation Trust, Southampton, England, United Kingdom.

Nathalie Caversaccio (N)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital of Bern, University of Bern, Bern, Switzerland.

Suzanne Crowley (S)

Paediatric Department of Allergy and Lung Diseases, Oslo University Hospital, Oslo, Norway.

Sinan Ahmed D Dheyauldeen (SAD)

Department of Otorhinolaryngology-Head and Neck Surgery, Oslo University Hospital, Oslo, Norway.
Faculty of Medicine, University of Oslo, Oslo, Norway.

Nagehan Emiralioglu (N)

Department of Pediatric Pulmonology, Hacettepe University School of Medicine, Ankara, Turkey.

Ela Erdem (E)

Department of Pediatric Pulmonology, Marmara University School of Medicine, Istanbul, Turkey.

Christine van Gogh (C)

Department of Otorhinolaryngology-Head and Neck Surgery, Amsterdam UMC, Amsterdam, the Netherlands.

Onder Gunaydin (O)

Department of Otorhinolaryngology, Hacettepe University School of Medicine, Ankara, Turkey.

Eric G Haarman (EG)

Department of Pediatric Pulmonology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.

Amanda Harris (A)

Primary Ciliary Dyskinesia Centre, NIHR Respiratory Biomedical Research Centre, University of Southampton, Southampton, England, United Kingdom.

Isolde Hayn (I)

Department of Otorhinolaryngology-Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Hasnaa Ismail-Koch (H)

Primary Ciliary Dyskinesia Centre, Southampton Children's Hospital, Southampton NHS Foundation Trust, Southampton, England, United Kingdom.

Bulent Karadag (B)

Department of Pediatric Pulmonology, Marmara University School of Medicine, Istanbul, Turkey.

Céline Kempeneers (C)

Division of Respirology, Department of Pediatrics, University Hospital Liège, Liège, Belgium.

Sookyung Kim (S)

Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Hôpital Bicêtre, Service d'ORL, Le Kremlin-Bicêtre, France.

Natalie Lorent (N)

Department of Respiratory Diseases, University Hospital, Leuven, Belgium.

Ugur Ozcelik (U)

Department of Pediatric Pulmonology, Hacettepe University School of Medicine, Ankara, Turkey.

Charlotte Pioch (C)

Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Anne-Lise M L Poirrier (AML)

Department of Otorhinolaryngology, University Hospital Liège, Liège, Belgium.

Ana Reula (A)

Biomedical Sciences Department, CEU-Cardenal Herrera University, Castellón, Spain.
Molecular, Cellular and Genomic Biomedicine Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.

Jobst Roehmel (J)

Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Panayiotis Yiallouros (P)

University of Cyprus Medical School, Nicosia, Cyprus.
Pediatric Pulmonology Unit, Archbishop Makarios III Hospital, Nicosia, Cyprus.

Ali Cemal Yumusakhuylu (AC)

Department of Otolaryngology, Marmara University School of Medicine, Istanbul, Turkey.

Jean-François Papon (JF)

Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Hôpital Bicêtre, Service d'ORL, Le Kremlin-Bicêtre, France.
Faculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH